(Q51899584)

17 April 2018

title

Switching from methylphenidate immediate release to MPH-SODAS in attention-deficit/hyperactivity disorder. (English)

1 reference

17 April 2018

attention deficit hyperactivity disorder

1 reference

1 reference

4

1 reference

17 April 2018

author name string

Carlos Renato Moreira Maia

series ordinal

1

1 reference

17 April 2018

Breno Córdova Matte

series ordinal

2

1 reference

17 April 2018

Henrique Tschoepke Ludwig

series ordinal

3

1 reference

17 April 2018

publication date

1 April 2008

1 reference

17 April 2018

European Child & Adolescent Psychiatry

published in

1 reference

17 April 2018

volume

17

1 reference

17 April 2018

issue

3

1 reference

17 April 2018

page(s)

133-142

1 reference

17 April 2018

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00787-007-0647-7

Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation

21 January 2018

1 reference

12 December 2020

Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour

1 reference

12 December 2020

Which treatment for whom for ADHD? Moderators of treatment response in the MTA.

1 reference

12 December 2020

Interrater agreement for the schedule for affective disorders and schizophrenia epidemiological version for school-age children (K-SADS-E).

1 reference

12 December 2020

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment

1 reference

12 December 2020

Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry

1 reference

12 December 2020

Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder

1 reference

12 December 2020

An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan.

1 reference

12 December 2020

Pharmacological management of treatment-induced insomnia in ADHD.

1 reference

12 December 2020

Predicting the response of hyperkinetic children to stimulant drugs: a review

1 reference

12 December 2020

Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS MPH Results of a 3-week open-label study

1 reference

12 December 2020

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

12 December 2020

Accounting for dropout bias using mixed-effects models.

1 reference

12 December 2020

Is age-at-onset criterion relevant for the response to methylphenidate in attention-deficit/hyperactivity disorder?

1 reference

12 December 2020

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

1 reference

12 December 2020

Methylphenidate bioavailability from two extended-release formulations

1 reference

12 December 2020

Modelling covariance structure in the analysis of repeated measures data

1 reference

12 December 2020

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline

1 reference

12 December 2020

Weekend holidays during methylphenidate use in ADHD children: a randomized clinical trial

1 reference

12 December 2020

Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults

1 reference

12 December 2020

Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day.

1 reference

12 December 2020

Are we ready for endophenotypes in attention deficit hyperactivity disorder?

1 reference

12 December 2020

Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation

1 reference

12 December 2020

ADHD in Brazil: the DSM-IV criteria in a culturally different population

1 reference

12 December 2020

Determinants of Adherence to Methylphenidate and the Impact of Poor Adherence on Maternal and Family Measures

1 reference

12 December 2020

Comparison of the clinical efficacy of twice-daily Ritalin and once-daily Equasym XL with placebo in children with Attention Deficit/Hyperactivity Disorder

1 reference

12 December 2020

Review of safety assessment methods used in pediatric psychopharmacology

1 reference

12 December 2020

Lack of gender effects on subtype outcomes in adults with attention-deficit/hyperactivity disorder: support for the validity of subtypes.

1 reference

12 December 2020

A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder

1 reference

12 December 2020

Factors influencing elementary school teachers' ratings of ADHD and ODD behaviors.

1 reference

12 December 2020

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings

1 reference

12 December 2020

PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate

1 reference

12 December 2020

12-month efficacy and safety of OROS MPH in children and adolescents with attention-deficit/hyperactivity disorder switched from MPH.

1 reference

12 December 2020

[Interrater reliability for diagnosis in adults of attention deficit hyperactivity disorder and oppositional defiant disorder using K-SADS-E]

1 reference

12 December 2020

European clinical guidelines for hyperkinetic disorder -- first upgrade

1 reference

12 December 2020

Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications

1 reference

12 December 2020

[Switching from a short-acting to a long-acting methylphenidate preparation: a multicentre, open study in children with ADHD]

1 reference

12 December 2020

In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers

1 reference

12 December 2020

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

1 reference

12 December 2020

Response to methylphenidate in boys with attention-deficit hyperactivity disorder.

1 reference

12 December 2020

Long-term effects of stimulant medications on the brain: possible relevance to the treatment of attention deficit hyperactivity disorder

1 reference

12 December 2020

Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.

1 reference

12 December 2020

Psychiatric interviews suitable for use in research with children and adolescents.

1 reference

12 December 2020

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

1 reference

12 December 2020

Comparative efficacy of once-a-day extended-release methylphenidate, two-times-daily immediate-release methylphenidate, and placebo in a laboratory school setting

1 reference

12 December 2020

10.1007/S00787-007-0647-7

Identifiers

DOI

1 reference

17 April 2018

1 reference

17 April 2018